Mitotane generally requires several courses of treatment before the effect is seen

Mitotane (Mitotane) is a drug used to treat adrenocortical cancer (ACC). It has inhibitory adrenocortical function and anti-tumor activity. Due to the particularity of the disease and the pharmacological characteristics of mitotane, it usually takes a certain period of time for patients to observe significant effects when taking mitotane treatment. The length of the specific course of treatment varies depending on individual differences, severity of the condition, and adjustment of medication dosage.

Generally speaking, treatment with mitotane takes several months to show effects. Clinically, it is usually recommended that patients take at least 3 to 6 months of treatment. During this period, blood concentration and the patient's adrenal function need to be closely monitored. Mitotane has a long half-life and slow accumulation in the body, so it is difficult to quickly reach therapeutic concentrations in the short term. It takes time to gradually accumulate to exert the effect of inhibiting tumors and reducing hormone secretion.

In addition, the assessment of efficacy of mitotane depends on the patient's specific pathology and clinical response. In some patients, after taking the drug for several months, imaging examinations may show that the tumor size has decreased or the growth has stabilized, and the hormone levels have also been controlled. For symptoms of hyperadrenocorticism, mitotane can gradually alleviate related manifestations, such as hypertension, hirsutism, and electrolyte imbalance. But this usually requires continuous medication and other auxiliary treatments to achieve better results.

Finally, because mitotane may cause certain side effects, such as gastrointestinal discomfort, nervous system reactions, and liver function abnormalities, doctors will adjust the dosage and treatment length according to the patient's tolerance. Some patients may need to take mitotane long-term to maintain stable disease. Therefore, patients should be reviewed regularly during treatment and follow the doctor's instructions for drug management and efficacy evaluation to ensure the best therapeutic effect.

Reference materials:https://go.drugbank.com/drugs/DB00648